Generate Biomedicines, Inc. Common Stock (NASDAQ: GENB) last traded at $13.84, down 3.49% on the session. The quote above updates while this page is open; the figures below are drawn from Generate Biomedicines, Inc. Common Stock’s own filings and are restated only when a new one is published.
Generate Biomedicines, Inc. Common Stock trades on NASDAQ under the ticker GENB. Its market capitalisation is $1.78 billion.
Valuation measures for Generate Biomedicines, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.78B |
|---|---|
| Enterprise value | $1.75B |
| Price / book | 3.90 |
| Beta | 1.33 |
Trailing-twelve-month figures tagged in Generate Biomedicines, Inc. Common Stock's XBRL filings with the SEC.
| Cash |
|---|
| $135.36M |
Range and volume for GENB over the past 52 weeks.
| 52-week high | $22.67 |
|---|---|
| 52-week low | $11.00 |
| Volume | 673.8K |
| Average volume | 1.04M |
| Previous close | $14.34 |
Invest a chosen dollar amount in Generate Biomedicines, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GENB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.